Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model.

Gleysteen JP, Newman JR, Chhieng D, Frost A, Zinn KR, Rosenthal EL.

Head Neck. 2008 Jun;30(6):782-9. doi: 10.1002/hed.20782.

2.

Near-infrared fluorescent labeled peptosome for application to cancer imaging.

Tanisaka H, Kizaka-Kondoh S, Makino A, Tanaka S, Hiraoka M, Kimura S.

Bioconjug Chem. 2008 Jan;19(1):109-17. doi: 10.1021/bc7001665. Epub 2007 Dec 29.

PMID:
18163535
3.

Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.

Sampath L, Kwon S, Ke S, Wang W, Schiff R, Mawad ME, Sevick-Muraca EM.

J Nucl Med. 2007 Sep;48(9):1501-10.

4.

Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future.

Sun D, Bloomston M, Hinkle G, Al-Saif OH, Hall NC, Povoski SP, Arnold MW, Martin EW Jr.

J Surg Oncol. 2007 Sep 15;96(4):297-308.

PMID:
17726663
5.

Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts.

Kulbersh BD, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL.

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):511-5.

PMID:
17520766
6.

Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.

Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR.

Mol Cancer Ther. 2007 Apr;6(4):1230-8.

7.

Population pharmacokinetics of humanized monoclonal antibody HuCC49deltaCH2 and murine antibody CC49 in colorectal cancer patients.

Fang L, Holford NH, Hinkle G, Cao X, Xiao JJ, Bloomston M, Gibbs S, Saif OH, Dalton JT, Chan KK, Schlom J, Martin EW Jr, Sun D.

J Clin Pharmacol. 2007 Feb;47(2):227-37.

PMID:
17244774
8.

Diffuse optical imaging and spectroscopy for cancer.

Xu RX, Povoski SP.

Expert Rev Med Devices. 2007 Jan;4(1):83-95. Review.

PMID:
17187474
9.

Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates.

Fang L, Battisti RF, Cheng H, Reigan P, Xin Y, Shen J, Ross D, Chan KK, Martin EW Jr, Wang PG, Sun D.

J Med Chem. 2006 Oct 19;49(21):6290-7.

10.

In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence.

Rosenthal EL, Kulbersh BD, Duncan RD, Zhang W, Magnuson JS, Carroll WR, Zinn K.

Laryngoscope. 2006 Sep;116(9):1636-41.

PMID:
16954995
11.

Pharmacokinetics and tumor localization of (111)in-labeled HuCC49DeltaC(H)2 in BALB/c mice and athymic murine colon carcinoma xenograft.

Chinn PC, Morena RA, Santoro DA, Kazules T, Kashmiri SV, Schlom J, Hanna N, Braslawsky G.

Cancer Biother Radiopharm. 2006 Apr;21(2):106-16.

PMID:
16706631
12.

Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.

Cheng Z, Levi J, Xiong Z, Gheysens O, Keren S, Chen X, Gambhir SS.

Bioconjug Chem. 2006 May-Jun;17(3):662-9.

13.

Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu.

Mohsin H, Jia F, Sivaguru G, Hudson MJ, Shelton TD, Hoffman TJ, Cutler CS, Ketring AR, Athey PS, Simón J, Frank RK, Jurisson SS, Lewis MR.

Bioconjug Chem. 2006 Mar-Apr;17(2):485-92.

PMID:
16536481
14.

Sentinel lymph node mapping of the gastrointestinal tract by using invisible light.

Soltesz EG, Kim S, Kim SW, Laurence RG, De Grand AM, Parungo CP, Cohn LH, Bawendi MG, Frangioni JV.

Ann Surg Oncol. 2006 Mar;13(3):386-96. Epub 2006 Jan 31.

PMID:
16485157
15.

Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.

Cheng Z, Wu Y, Xiong Z, Gambhir SS, Chen X.

Bioconjug Chem. 2005 Nov-Dec;16(6):1433-41.

16.

Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.

Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ.

Cancer Biother Radiopharm. 2005 Oct;20(5):502-13. Erratum in: Cancer Biother Radiopharm. 2005 Dec;20(6):671.

PMID:
16248766
17.

Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients.

Xiao J, Horst S, Hinkle G, Cao X, Kocak E, Fang J, Young D, Khazaeli M, Agnese D, Sun D, Martin E Jr.

Cancer Biother Radiopharm. 2005 Feb;20(1):16-26.

PMID:
15778575
18.

Infrared ray electronic endoscopy combined with indocyanine green injection for detection of sentinel nodes of patients with gastric cancer.

Nimura H, Narimiya N, Mitsumori N, Yamazaki Y, Yanaga K, Urashima M.

Br J Surg. 2004 May;91(5):575-9.

PMID:
15122608
19.

Pilot study using a humanized CC49 monoclonal antibody (HuCC49DeltaCH2) to localize recurrent colorectal carcinoma.

Agnese DM, Abdessalam SF, Burak WE Jr, Arnold MW, Soble D, Hinkle GH, Young D, Khazaeli MB, Martin EW Jr.

Ann Surg Oncol. 2004 Feb;11(2):197-202.

PMID:
14761924
20.

Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.

Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, Sevick-Muraca EM, Li C.

Cancer Res. 2003 Nov 15;63(22):7870-5.

Items per page

Supplemental Content

Write to the Help Desk